International AIDS Vaccine Initiative | IAVI - International AIDS Vaccine Initiative

Call for Global Health Case Study Submissions

Strengthening the response to HIV and AIDS: Helping make the MDGs a reality

Leading global health organizations recently joined together to form the Global Health Case Study Initiative. If you are involved in global health, you are encouraged to submit case studies highlighting best practices at casestudiesforglobalhealth.org.

New Online Video Forum Features Dr. Seth Berkley

New Online Video Forum Features Seth Berkley

Seth Berkley, president and CEO of IAVI, discusses the future of AIDS vaccine research in a series of video interviews featured on the BigThink.com—a first-of-its-kind site for idea sharing and discussion between global thought leaders.
READ MORE >

HIV/AIDS: The Search for a Vaccine

Originally aired as part of BBC World’s Kill or Cure? series, this four-minute documentary features AIDS specialists, researchers, and community workers discussing the impact of HIV/AIDS on their communities and their efforts to find a solution to the epidemic.
WATCH THE VIDEO
DOWNLOAD THE PODCAST

What is a vaccine?

A vaccine is a substance that is introduced into the body to prevent infection or to control disease due to a certain pathogen (any disease-causing organism, such as a virus, bacterium or parasite); the vaccine 'teaches' the body how to defend itself against a pathogen by creating an immune response.
LEARN MORE >

Why the world needs an AIDS vaccine

Despite the international community's best efforts, the HIV pandemic continues unabated. In 2006, more than 39 million people were living with HIV worldwide. Over four million people became newly infected with HIV and an estimated 2.8 million lost their lives to AIDS.
LEARN MORE >

Latest News

^{[what's this?]}

NYC To Celebrate Opening of AIDS Vaccine Laboratory on November 12

IAVI will open a state-of-the-art AIDS vaccine lab at the landmark Brooklyn Army Terminal during a ribbon-cutting ceremony on November 12.

IAVI Commends UK Government’s Commitment to Ending AIDS

The UK government announced today it would contribute £220 million over five years to support product development research for new tools to stop the spread of HIV.

IAVI Releases 2008 AIDS Vaccine Blueprint

In its biennial AIDS Vaccine Blueprint: A Challenge to the Field, a Roadmap for Progress, IAVI puts forth a series of concrete recommendations to help guide future AIDS vaccine research and development, including a series of interim milestones against which progress in the field can be charted.

South Africa Plays Role in AIDS Vaccine Discovery Efforts

IAVI awards South Africa’s Elevation Biotech with an innovation grant to help develop novel vaccine immunogens that elicit broadly neutralizing antibodies against HIV.

New AIDS Vaccine Research Center Established

IAVI and The Scripps Research Institute have launched the world’s first research center dedicated exclusively to solving the most pressing challenge facing AIDS vaccine researchers today—how to elicit broadly neutralizing antibodies against HIV.

Strengthening the response to HIV and AIDS: Helping make the MDGs a reality

A new IAVI policy brief, endorsed by 43 partner organizations, examines the critical role that the response to HIV/AIDS plays in advancing the Millennium Development Goals.

MORE NEWS >